FCA Health Innovations II QP
Brentwood, US · Founded 2020 · Delaware limited partnership
Founders & leadership
NS
Nancy S AllenNamed on SEC filing
AJ
Andrew J BouldinNamed on SEC filing
JR
John R Burch, Jr.Named on SEC filing
JA
James A PattonNamed on SEC filing
C(
Charles (Todd) W JohnsonNamed on SEC filing
MA
Matthew A KingNamed on SEC filing
WH
Whitney H KalbNamed on SEC filing
TK
Thomas K Hearn IIINamed on SEC filing
Reported raises · per SEC filings
Form D private placements$55.1M disclosed across 1 round · 2020
▶$55.1MraisedFeb 2022 · 129 investors · Other Health CareRule 506(b)
▶$55.1MraisedFeb 2022 · 129 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Nancy S AllenExecutive Officer, Promoter
- Andrew J BouldinExecutive Officer, Promoter
- John R Burch, Jr.Executive Officer, Promoter
- FCA Health Innovations II SLP, LLCExecutive Officer
- FCA Health Innovations II GP, LLCExecutive Officer, Promoter
- FCA Health Innovations II Management, LLCExecutive Officer
- James A PattonExecutive Officer, Promoter
- Charles (Todd) W JohnsonDirector, Promoter
- Matthew A KingDirector, Promoter
- Whitney H KalbExecutive Officer, Promoter
- Thomas K Hearn IIIDirector, Promoter
- Offering amount
- $66M
- Amount sold
- $55.1M
- Minimum investment
- $25K
- First sale
- Nov 2020
- Incorporated
- Limited Partnership, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has FCA Health Innovations II QP raised?
- FCA Health Innovations II QP has disclosed $55.1M raised across 1 round.
- Where is FCA Health Innovations II QP headquartered?
- FCA Health Innovations II QP is headquartered in Brentwood, US.